These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30727971)

  • 1. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
    Sauboin C; Holl K; Bonanni P; Gershon AA; Benninghoff B; Carryn S; Burgess MA; Wutzler P
    BMC Infect Dis; 2019 Feb; 19(1):126. PubMed ID: 30727971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
    EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.
    Poletti P; Melegaro A; Ajelli M; Del Fava E; Guzzetta G; Faustini L; Scalia Tomba G; Lopalco P; Rizzo C; Merler S; Manfredi P
    PLoS One; 2013; 8(4):e60732. PubMed ID: 23613740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS; King PG
    Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
    Widgren K; Tomba GS; Leung KY; Giesecke J
    Vaccine; 2022 Jan; 40(4):673-681. PubMed ID: 34930603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study.
    Melegaro A; Marziano V; Del Fava E; Poletti P; Tirani M; Rizzo C; Merler S
    BMC Med; 2018 Jul; 16(1):117. PubMed ID: 30012132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
    Harpaz R; van Hoek AJ
    J Infect Dis; 2018 Sep; 218(suppl_2):S57-S62. PubMed ID: 30247602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes zoster in the context of varicella vaccination - An equation with several variables.
    Wutzler P; Casabona G; Cnops J; Akpo EIH; Safadi MAP
    Vaccine; 2018 Nov; 36(46):7072-7082. PubMed ID: 30309745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
    Suh J; Lee T; Choi JK; Lee J; Park SH
    Vaccine; 2021 Apr; 39(18):2575-2583. PubMed ID: 33814230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
    Goldman GS
    Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
    Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
    BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the role of exogenous boosting in modeling varicella vaccination.
    Talbird SE; La EM; Mauskopf J; Altland A; Daniels V; Wolfson LJ
    Expert Rev Vaccines; 2018 Nov; 17(11):1021-1035. PubMed ID: 30354696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models for optimally controlling varicella and herpes zoster by varicella vaccination: a comparative study.
    Betta M; Landi A; Manfredi P; Laurino M
    Med Biol Eng Comput; 2019 May; 57(5):1121-1132. PubMed ID: 30652233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.